# Exhibit Review — Gemini 3 Flash (Round 1)

**Role:** Visual exhibit advisor
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-19T10:35:58.071461
**Route:** Direct Google API + PDF
**Tokens:** 18917 in / 1715 out
**Response SHA256:** c15fb215ac460192

---

# Exhibit-by-Exhibit Review

## Main Text Exhibits

### Table 1: "Summary Statistics"
**Page:** 10
- **Formatting:** Generally professional and clean. Numbers are not perfectly decimal-aligned (centered instead). Uses appropriate horizontal lines (booktabs style).
- **Clarity:** Clear. Logic of showing Full, Treated, and Control is standard and easy to parse.
- **Storytelling:** Essential. It establishes that Treated and Control states are similar in baseline death rates.
- **Labeling:** Good. Footnotes define the drug categories (T40.2, etc.) and units.
- **Recommendation:** **REVISE**
  - Decimal-align the values in the columns for better readability.
  - Add a column for the difference between EPCS and Non-EPCS states with a p-value for a t-test of means. Top journals expect to see if baseline differences are statistically significant.

### Figure 1: "Staggered Adoption of State EPCS Mandates"
**Page:** 14
- **Formatting:** Clean "cleandot" plot. High contrast. Vertical dashed line for CMS mandate is a good touch.
- **Clarity:** Very high. One of the strongest figures; immediately shows the "waves" of adoption.
- **Storytelling:** Excellent. It justifies the use of a staggered DiD design.
- **Labeling:** Labels on both axes are clear. 
- **Recommendation:** **KEEP AS-IS**

### Figure 2: "Prescription Opioid Death Rates by EPCS Adoption Cohort"
**Page:** 15
- **Formatting:** Modern ggplot style. Ribbon confidence intervals are a bit overlapping/cluttered.
- **Clarity:** Moderate. The many overlapping ribbons make it hard to see the "Never Treated" line clearly.
- **Storytelling:** Important for showing raw trends.
- **Labeling:** Clear legend. 
- **Recommendation:** **REVISE**
  - Thin the ribbons or use dashed lines for some cohorts to reduce the "blob" effect.
  - Highlight the "Never Treated" line with a thicker or darker weight (e.g., black) as it is the primary counterfactual.

### Figure 3: "U.S. Drug Overdose Deaths by Opioid Type, 2015–2023"
**Page:** 16
- **Formatting:** Professional. Simple line chart.
- **Clarity:** High. The message (Fentanyl is rising, Rx is flat/falling) is immediate.
- **Storytelling:** Critical context. It explains why the "Level" effects might be hard to find and why the "Log" results (proportionality) matter more.
- **Labeling:** Good axis labels and legend.
- **Recommendation:** **KEEP AS-IS**

### Table 2: "Effect of EPCS Mandates on Opioid Overdose Deaths"
**Page:** 17
- **Formatting:** Logical panel structure (A, B, C). Clear grouping.
- **Clarity:** High. Compares estimators and drug classes side-by-side.
- **Storytelling:** The core result of the paper. Shows the "Null-in-levels" result for the main outcome and placebo.
- **Labeling:** Well-noted. Defines estimators (CS, TWFE, Sun-Abraham).
- **Recommendation:** **REVISE**
  - This table should include a "Panel D: Log Specification." The author states in the abstract and text that the Log results are the most precise and significant. For AER/QJE, the main table must contain the headline significant finding, not just the imprecise level results.

### Figure 4: "Event Study: Treatment (Prescription Opioids) vs. Placebo (Synthetic Opioids)"
**Page:** 19
- **Formatting:** Two-panel vertical layout. Consistent scales within panels.
- **Clarity:** High. Shows the contrast between treatment and placebo.
- **Storytelling:** Very strong. Visually proves no pre-trends and highlights the divergence in the treatment period.
- **Labeling:** Y-axis clearly states units.
- **Recommendation:** **KEEP AS-IS**

### Table 3: "Robustness of EPCS Mandate Effects on Prescription Opioid Deaths"
**Page:** 20
- **Formatting:** Clean row-by-row comparison.
- **Clarity:** Very high. 
- **Storytelling:** Consolidates all the "What if..." questions into one place. 
- **Labeling:** Significance stars present (** for the log result).
- **Recommendation:** **KEEP AS-IS** (Though potentially merge into Table 2 if space allows).

---

## Appendix Exhibits

### Table 4: "State EPCS Mandate Adoption Dates"
**Page:** 30
- **Formatting:** Simple list. 
- **Clarity:** Very easy to find a specific state.
- **Storytelling:** Necessary for replication and transparency.
- **Labeling:** Clear list of never-treated states in the footer.
- **Recommendation:** **KEEP AS-IS**

### Figure 5: "Event Study: EPCS Mandates and Prescription Opioid Deaths"
**Page:** 31
- **Formatting:** Standard ggplot.
- **Clarity:** High.
- **Storytelling:** **REDUNDANT.** This is exactly the same as the top panel of Figure 4 in the main text.
- **Labeling:** Clear.
- **Recommendation:** **REMOVE** (It is already in Figure 4).

### Figure 6: "Placebo Test: EPCS Mandates and Synthetic Opioid Deaths"
**Page:** 32
- **Formatting:** Standard ggplot.
- **Clarity:** High.
- **Storytelling:** **REDUNDANT.** This is exactly the same as the bottom panel of Figure 4 in the main text.
- **Labeling:** Clear.
- **Recommendation:** **REMOVE** (It is already in Figure 4).

### Figure 7: "Raw Outcome Trends by EPCS Adoption Cohort (with 95% CI)"
**Page:** 34
- **Formatting:** Overlapping ribbons.
- **Clarity:** Low due to clutter.
- **Storytelling:** **REDUNDANT.** This is identical to Figure 2 in the main text.
- **Labeling:** Clear.
- **Recommendation:** **REMOVE** (Duplicate of Figure 2).

---

## Overall Assessment

- **Exhibit count:** 3 main tables, 4 main figures, 1 appendix table, 3 appendix figures (redundant).
- **General quality:** The figures are very modern and high-quality. The tables are standard and clean. The biggest issue is redundancy in the appendix.
- **Strongest exhibits:** Figure 1 (Rollout) and Figure 4 (Event Study comparison).
- **Weakest exhibits:** Figure 2/7 (too much ribbon overlap) and Table 2 (missing the most important "Log" results).
- **Missing exhibits:** A map of the U.S. showing EPCS adoption would be a very standard "Figure 1" for a state-level policy paper.

### Top 3 Improvements:
1.  **Consolidate and Clean Appendix:** Remove Figures 5, 6, and 7 from the appendix as they are identical to main text figures. Instead, add new robustness figures there (e.g., Rambachan-Roth sensitivity plots).
2.  **Move Headline Result to Table 2:** Add the Log Specification as a panel in Table 2. Currently, a reader looking only at Table 2 would think the paper has no significant results.
3.  **Improve Table 1 (Balance):** Add a "Difference" column and t-stats to the summary statistics table to formally show that EPCS and non-EPCS states were balanced at baseline.